Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 150,000 shares at $40.08 ($5.6M) on 2020-04-01, disclosed to the SEC on 2020-04-03.
Open-market sale of $5.6M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.29 | 58,682 | $2.2M | 38.8% |
| 2 | $37.29 | 58,682 | $2.2M | 38.8% |
| 3 | $38.13 | 11,672 | $445K | 7.9% |
| 4 | $38.13 | 11,672 | $445K | 7.9% |
| 5 | $39.29 | 2,480 | $97K | 1.7% |
| 6 | $39.29 | 2,480 |
| $97K |
| 1.7% |
| 7 | $40.08 | 2,166 | $87K | 1.5% |
| 8 | $40.08 | 2,166 | $87K | 1.5% |
| Total | $37.57 avg | 150,000 | $5.6M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |